Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study” - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum: "Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Patients with Type 2 Diabetes - Insights from a Real-World Analysis

  • August 26, 2025

Share

Objective:

To correct errors in authorship and funding sections of the original article.

Key Findings:
  • Benaya Rozen-Zvi's name was corrected from 'Benaya Rozen Zvi' to 'Benaya Rozen-Zvi'.
  • Anat Gafter-Gvili's name was corrected from 'Anat Gafter Gvili' to 'Anat Gafter-Gvili'.
Interpretation:

The corrections ensure proper attribution and acknowledgment of the authors involved in the study.

Limitations:
  • The erratum does not address any scientific findings or data from the original study.
Conclusion:

The article has been corrected online to reflect accurate authorship and funding details.

Original Source(s)

Correction to: “The Beneficial Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Anemia in Type 2 Diabetes-A Real-World Study”

  • August 26, 2025

Related Content

Correction: Positive associations between sex hormones, bone metabolism and cognitive impairment in Chinese oldest-old females

Obesity and Early Biologic Failure in Psoriasis: An Italian Multicentre Retrospective Cohort Study

Inside the $10 Optical Spectrometer

The wrist-mounted probe collects near-infrared spectra for exploratory monitoring of human biomarkers

  • October 27, 2026

  • 3 min